Tetraphase Reports Third-Quarter 2013 Financial Results

18-11-2013 Business Wire HealthComments (0)

PharmaceuticalTetraphase Pharmaceuticals

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results for the quarter ended September 30, 2013. “The third quarter of 2013 was a productive one for us,” said Guy Macdonald, Tetraphase President and Chief Executive Officer. “We not only advanced our lead antibiotic candidate eravacycline into pivotal clinical trial development, with the start of a Phase 3 clinical trial for the treatment of complicated intra-abdominal infections, but a

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top